CompletedNCT00208208
Ziprasidone for post-traumatic stress symptoms
About this title
Geodon (Ziprasidone) for Posttraumatic Stress Disorder
Read the official source — NCT00208208Medication studyAges 19–64United StatesPTSD
Understand this study
Who was this study for?
Listed age limits: 19 years to 64 years.
- Listed locations
- OmahaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateDecember 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 80
- Sponsor
- Creighton University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 19 Years to 64 Years
- Official registry ID
- NCT00208208
- Official title
Show the full official title
Geodon (Ziprasidone) for Posttraumatic Stress Disorder
Get this study by email
Recruitment & locations
CompletedOmaha
Questions about this study
Who is behind this study?
The study sponsor is Creighton University, a university.
Did this study involve medication?
Yes. The study involved medication, including Ziprasidone.
Who was this study for?
Listed age limits: 19 years to 64 years.
